T1	Participants 55 93	subjects with mild-to-moderate asthma.
T2	Participants 161 198	subjects with mild-to-moderate asthma
T3	Participants 200 390	three groups of 11 patients were treated with nedocromil sodium (NS), beclomethasone dipropionate (BDP) and beclomethasone dipropionate plus salmeterol (BDP + S) in an open, randomized study
